共 71 条
[1]
Hilhorst M(2015)Proteinase 3-ANCA vasculitis versus myeloperoxidase-ANCA vasculitis J Am Soc Nephrol 26 2314-2327
[2]
Jennette JC(2013)2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides Arthritis Rheum 65 1-11
[3]
Heeringa P(2004)Pathophysiology of ANCA-associated vasculitides: are ANCA really pathogenic? Kidney Int 65 1564-1567
[4]
Tervaert JW(2003)Renal survival and prognostic factors in patients with PR3-ANCA associated vasculitis with renal involvement Kidney Int 63 670-677
[5]
Slot MC(2012)Antineutrophil cytoplasmic autoantibodies: how are they detected and what is their use for diagnosis, classification and follow-up? Clin Rev Allergy Immunol 43 211-219
[6]
Cohen Tervaert JW(2019)Should proteinase-3 and myeloperoxidase anti-neutrophil cytoplasmic antibody vasculitis be treated differently: part 2 Nephrol Dial Transplant 34 384-387
[7]
Damoiseaux J(2012)Classification of antineutrophil cytoplasmic autoantibody vasculitides: the role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis Arthritis Rheum 64 3452-3462
[8]
Cohen Tervaert JW(2016)Factors determining the clinical utility of serial measurements of antineutrophil cytoplasmic antibodies targeting proteinase 3 Arthritis Rheumatol 68 1700-1710
[9]
Lionaki S(2019)Increased ischemic stroke, acute coronary artery disease and mortality in patients with granulomatosis with polyangiitis and microscopic polyangiitis J Autoimmun 96 134-141
[10]
Fussner LA(2013)Cardiovascular disease due to accelerated atherosclerosis in systemic vasculitides Best Pract Res Clin Rheumatol 27 33-44